Coronary triglyceride deposition in contemporary advanced diabetics

Yoshihiko Ikeda1, Nobuhiro Zaima, Ken-ichi Hirano

  • 1Department of Pathology, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

Insights

Advanced diabetes mellitus is linked to increased triglyceride deposit cardiomyovasculopathy (TGCV), characterized by abnormal fat accumulation in coronary arteries and heart muscle. This study investigated TG deposition in autopsied diabetic hearts, revealing significant arterial TG accumulation in diabetic subjects.

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Pathology

Background:

  • Diabetic heart diseases, including heart failure and coronary artery disease, require further pathophysiological clarification.
  • A novel phenotype, triglyceride deposit cardiomyovasculopathy (TGCV), involves aberrant triglyceride (TG) accumulation in coronary arteries and myocardium.
  • Previous findings were based on a single cardiac transplant recipient.

Purpose of the Study:

  • To investigate TG deposition in the cardiovasculature of autopsied individuals with advanced diabetes mellitus (DM).
  • To compare TG levels and distribution in coronary arteries between diabetic and non-diabetic subjects.
  • To explore the association between TG deposition and advanced DM.

Main Methods:

  • Examination of autopsied hearts from 20 advanced DM subjects (DMG) and 20 age/sex-matched non-diabetic controls (NDMG).
  • Biochemical measurement of tissue TG content.
  • Imaging Mass Spectrometry for spatial TG distribution analysis in coronary arteries.

Main Results:

  • Coronary arterial TG content was significantly higher in the DM group compared to the non-DM group.
  • TG deposition in coronary arteries was primarily observed in smooth muscle cells.
  • All DMG subjects had heart diseases, with 14 exhibiting multi-vessel coronary artery disease.

Conclusions:

  • Abundant TG deposition in coronary arteries is associated with advanced diabetes mellitus.
  • The findings support the concept of TGCV in a broader diabetic population.
  • Further research is warranted to elucidate the precise mechanisms and clinical implications of TG deposition in diabetic cardiovascular disease.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
888
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
19
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.4K
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
12